March 16 (Reuters) – A federal jury has ruled in favor of Amgen Inc and against Sanofi SA and Regeneron Pharmaceuticals Inc in a trial over the validity of patents for antibodies related to a…
The post U.S. jury rules for Amgen over cholesterol drug patents appeared first on NASDAQ.